Literature DB >> 7717206

Metastases: mechanisms, pathways, and cascades.

J H Morgan-Parkes1.   

Abstract

Metastases are the major cause of treatment failure in cancer patients. Sixty percent of patients with newly diagnosed solid tumors (excluding skin cancers other than melanoma) have clinically evident or microscopic metastases when the primary tumor is diagnosed [1]. Dissemination of malignant cells throughout the body and their survival to form secondary growths constitute a complicated process dependent on both host and tumor properties. This review outlines the mechanisms involved in the metastatic process, the pathways of tumor spread throughout the body, and the common routes used by various tumors.

Entities:  

Mesh:

Year:  1995        PMID: 7717206     DOI: 10.2214/ajr.164.5.7717206

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

1.  Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.

Authors:  L C van Kempen; J J van den Oord; G N van Muijen; U H Weidle; H P Bloemers; G W Swart
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Inguinal metastasis in gastric cancer-a path less trodden.

Authors:  P Rajesh Prabhu; Jijo V Cherian; S Joye Varghese; K R Gunaseelan; A Murali; V Jayanthi
Journal:  Gastrointest Cancer Res       Date:  2008-03

Review 3.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

4.  Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membrane.

Authors:  A M Sieuwerts; J G Klijn; J A Foekens
Journal:  Clin Exp Metastasis       Date:  1997-01       Impact factor: 5.150

5.  Tumor thrombus in the venous drainage pathways of primary, recurrent and metastatic disease on routine oncologic imaging studies: beyond hepatocellular and renal cell carcinomas.

Authors:  Sireesha Yedururi; HyunSeon Kang; Veronica L Cox; Sumedha Chawla; Ott Le; Evelyne M Loyer; Leonardo Marcal
Journal:  Br J Radiol       Date:  2019-04-24       Impact factor: 3.039

6.  Enhancement of overgrowth by gene interactions in lethal(2)giant discs imaginal discs from Drosophila melanogaster.

Authors:  M A Buratovich; P J Bryant
Journal:  Genetics       Date:  1997-10       Impact factor: 4.562

Review 7.  Current role of bone scan with phosphonates in the follow-up of breast cancer.

Authors:  Lorenzo Maffioli; Luigia Florimonte; Luca Pagani; Ivana Butti; Isabel Roca
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-16       Impact factor: 9.236

Review 8.  Lung metastases.

Authors:  C J Herold; A A Bankier; D Fleischmann
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 9.  Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes.

Authors:  Olga Golubnitschaja; Krishna Chander Sridhar
Journal:  Clin Exp Metastasis       Date:  2016-08-19       Impact factor: 5.150

Review 10.  Colorectal cancer: imaging surveillance following resection of primary tumour.

Authors:  Ken Miles; Guy Burkill
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.